Procter Gamble Financials

PGHL Stock   5,299  159.20  3.10%   
We recommend to use Procter Gamble Health fundamental analysis to see if markets are presently undervaluing or overvaluing the firm. Put it differently, this technique allows you to confirm available drivers of Procter Gamble Health as well as the relationship between them. We are able to interpolate and collect twenty-seven available financial ratios for Procter Gamble Health, which can be compared to its competitors. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of Procter Gamble to be traded at 6358.74 in 90 days. Key indicators impacting Procter Gamble's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Income6.4 B6.1 B
Sufficiently Up
Slightly volatile
  
Understanding current and past Procter Gamble Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Procter Gamble's financial statements are interrelated, with each one affecting the others. For example, an increase in Procter Gamble's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Procter Gamble's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Procter Gamble Health. Check Procter Gamble's Beneish M Score to see the likelihood of Procter Gamble's management manipulating its earnings.

Procter Gamble Stock Summary

Procter Gamble competes with India Glycols, Indo Borax, Kingfa Science, Alkali Metals, and Mahindra Logistics. Procter Gamble is entity of India. It is traded as Stock on NSE exchange.
Foreign Associate
  USA
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentIndia Stock View All
ExchangeNational Stock Exchange of India
ISININE199A01012
Business AddressPG Plaza, Mumbai,
SectorPharmaceuticals
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.pghealthindia.com
Phone91 22 6866 9000
You should never invest in Procter Gamble without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Procter Stock, because this is throwing your money away. Analyzing the key information contained in Procter Gamble's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Procter Gamble Key Financial Ratios

There are many critical financial ratios that Procter Gamble's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Procter Gamble Health reports annually and quarterly.

Procter Gamble Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets11.8B9.9B8.9B11.0B7.9B9.0B
Other Current Liab943.8M957.6M477.5M570.6M457.8M689.1M
Net Debt(6.4B)(4.6B)(3.2B)(4.2B)(2.3B)(2.5B)
Cash6.4B4.6B3.2B4.4B2.4B3.6B
Inventory1.4B1.2B1.2B1.3B1.1B1.3B
Other Current Assets811.6M849.1M1.8B1.1B854.2M866.7M
Total Liab2.7B2.8B2.8B3.5B2.6B2.1B
Total Current Assets9.6B7.3B6.1B8.0B5.2B6.7B
Retained Earnings5.3B3.3B2.4B3.7B4.3B4.0B
Accounts Payable1.2B1.3B1.7B2.4B1.7B1.2B
Net Receivables999.4M670.9M925.8M1.2B853.3M913.0M
Intangible Assets2.1M1.2M400K9.4M9.6M10.1M
Other Liab420.6M406.2M414M375.2M431.5M380.8M
Net Tangible Assets9.1B7.0B6.2B7.5B8.6B8.9B
Other Assets1.01.2B1.4B304.1M349.7M332.2M
Short Term Debt79M738.7M28.3M292M26.8M25.5M
Cash And Equivalents5.9B4.2B3.2B3.4B3.1B3.7B

Procter Gamble Key Income Statement Accounts

201920202021202220232024 (projected)
Interest Expense5.2M8M4.2M7.7M7.2M6.8M
Total Revenue9.0B9.9B10.9B12.3B11.5B9.1B
Gross Profit4.0B6.5B7.2B8.7B5.8B5.4B
Operating Income2.0B2.3B2.6B3.1B6.1B6.4B
Ebit2.0B2.3B2.5B3.1B2.8B1.7B
Ebitda2.2B2.6B2.8B3.4B3.1B1.9B
Cost Of Revenue5.0B3.4B3.7B3.6B5.7B3.8B
Income Before Tax2.4B2.3B2.5B3.1B2.7B1.8B
Net Income1.7B1.8B1.9B2.3B2.0B1.7B
Income Tax Expense671.8M564.8M608.5M847.3M723.4M497.9M
Research Development57.3M39.3M65.5M57.1M51.4M57.6M
Tax Provision1.0B564.8M608.5M847.3M723.4M691.9M
Interest Income599.2M8M4.2M7.7M6.9M6.6M

Procter Gamble Key Cash Accounts

201920202021202220232024 (projected)
Change To Inventory(207.5M)152.6M(20.2M)(323.9M)231.3M242.9M
Change In Cash(4.8B)(1.7B)(1.4B)1.2B(2.0B)(1.9B)
Free Cash Flow2.7B1.9B1.3B1.9B2.2B2.3B
Depreciation192.9M300.4M270.8M281M274M194.6M
Other Non Cash Items1.7B(163.5M)(670.4M)(156.1M)113.3M119.0M
Dividends Paid8.8B3.8B2.8B937.9M4.1B4.4B
Capital Expenditures232.7M525.8M379.2M424.8M217.3M303.5M
Net Income1.7B2.3B2.5B3.1B2.0B2.2B
End Period Cash Flow6.4B4.6B3.2B4.4B2.4B2.2B
Investments825.4M(322.7M)(255.4M)(215M)(68.7M)(65.3M)
Change To Netincome(282.9M)(121.3M)(32M)84.6M97.3M102.2M

Procter Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Procter Gamble's current stock value. Our valuation model uses many indicators to compare Procter Gamble value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Procter Gamble competition to find correlations between indicators driving Procter Gamble's intrinsic value. More Info.
Procter Gamble Health is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about  0.59  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Procter Gamble Health is roughly  1.69 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Procter Gamble's earnings, one of the primary drivers of an investment's value.

Procter Gamble Health Systematic Risk

Procter Gamble's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Procter Gamble volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was four with a total number of output elements of fifty-seven. The Beta measures systematic risk based on how returns on Procter Gamble Health correlated with the market. If Beta is less than 0 Procter Gamble generally moves in the opposite direction as compared to the market. If Procter Gamble Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Procter Gamble Health is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Procter Gamble is generally in the same direction as the market. If Beta > 1 Procter Gamble moves generally in the same direction as, but more than the movement of the benchmark.

Procter Gamble Health Total Assets Over Time

Procter Gamble Thematic Clasifications

Procter Gamble Health is part of Health Management investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Healthcare providers, hospitals. Major hospitals and healthcare providers
Health ManagementView
This theme covers Healthcare providers, hospitals. Major hospitals and healthcare providers. Get More Thematic Ideas

Procter Gamble November 27, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Procter Gamble help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Procter Gamble Health. We use our internally-developed statistical techniques to arrive at the intrinsic value of Procter Gamble Health based on widely used predictive technical indicators. In general, we focus on analyzing Procter Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Procter Gamble's daily price indicators and compare them against related drivers.

Additional Tools for Procter Stock Analysis

When running Procter Gamble's price analysis, check to measure Procter Gamble's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procter Gamble is operating at the current time. Most of Procter Gamble's value examination focuses on studying past and present price action to predict the probability of Procter Gamble's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procter Gamble's price. Additionally, you may evaluate how the addition of Procter Gamble to your portfolios can decrease your overall portfolio volatility.